StimCell Energetics, Inc. (STME)
0.477
+0.07
(+16.34%)
USD |
OTCM |
Jan 09, 14:57
StimCell Energetics Cash from Investing (Quarterly): 0.00 for Aug. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Achieve Life Sciences, Inc. | -12.65M |
| Venus Concept, Inc. | -0.017M |
| Oncolytics Biotech, Inc. | -0.0051M |
| Aurinia Pharmaceuticals, Inc. | -14.04M |
| Edesa Biotech, Inc. | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -0.1081M |
| Cash from Financing (Quarterly) | 0.10M |
| Free Cash Flow | -0.2291M |
| Free Cash Flow Per Share (Quarterly) | -0.0053 |
| Free Cash Flow to Equity (Quarterly) | -0.1973M |
| Free Cash Flow to Firm (Quarterly) | -0.0949M |
| Free Cash Flow Yield | -2.41% |